Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate Cellular Gene Expression

Area of Science:

• Hepatology
• Virology
• Molecular Biology

Background:

• Low serum 25-hydroxyvitamin D [25(OH)D] is linked to reduced responsiveness to interferon and ribavirin therapy for hepatitis C virus (HCV).
• The impact of vitamin D metabolites on HCV and cellular gene expression requires further investigation.

Purpose of the Study:

• To investigate the effects of vitamin D metabolites on HCV replication in cultured hepatoma cells.
• To evaluate the synergistic potential of vitamin D metabolites with interferon-alpha (IFN-α) in combating HCV.
• To analyze the impact of vitamin D on cellular gene expression in the context of HCV infection.

Main Methods:

• HCV replicon cell lines were treated with vitamin D2, vitamin D3, or 1,25-dihydroxyvitamin D3 (1,25(OH)2D3).
• HCV presence was quantified using luciferase reporter assays and Core protein immunoblotting.
• Synergy between 1,25(OH)2D3 and IFN-α was assessed using the Chou-Talalay method, with gene expression analyzed via microarray and qPCR.

Main Results:

• Vitamin D metabolites demonstrated anti-HCV activity at low micromolar concentrations.
• 1,25(OH)2D3 and IFN-α exhibited synergistic effects, significantly reducing HCV core protein expression.
• Vitamin D activated genes related to its metabolism and excretion, as well as autophagy-related genes (e.g., GPR37, HIF1a).
• Additive effects were observed between 1,25(OH)2D3 and IFN-α on CCL20 mRNA expression.

Conclusions:

• Vitamin D reduces HCV protein production in cell culture, acting synergistically with IFN-α.
• Vitamin D modulates cellular gene expression independently and additively with IFN-α.
• These findings suggest a potential role for vitamin D in aiding HCV clearance in vivo.